Valuation: genedrive plc

Market Cap 20.87M 27.77M 24.42M 22.73M 39.19M 2.66B 39.71M 270M 106M 1.32B 104M 102M 4.55B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.2M 23.03M 21.44M 36.97M 2.51B 37.46M 255M 99.54M 1.24B 98.35M 96.23M 4.29B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
Current month-19.23%
1 month-19.23%
3 months+13.51%
6 months-2.33%
Current year+20.00%
1 week 1
Extreme 1
1.1
1 month 0.98
Extreme 0.9755
1.5
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
15.38
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Director/Board Member 79 14/07/2026
Director/Board Member 52 22/08/2018
Director/Board Member 69 09/04/2018
Date Insider Type Main position Quantity % Market Cap.
20/12/24 Free 400,000 0.0736%
20/12/24 Free 400,000 0.0736%
20/12/24 Free

Chief Executive Officer

3,500,000 0.6444%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-20.75%-92.36% 22.49M
-3.03%-11.96%+12.14%-40.07% 15.54B
+4.07%+9.27%+1.83%+92.76% 1.65B
+4.86%-3.16%-38.55%-80.93% 1.09B
+1.20%-3.51%-37.83%+14.00% 948M
+3.70%-2.12%-43.46%-54.33% 609M
+1.10%-4.29%-50.51%-58.91% 505M
+0.55%+4.08%+39.87%-52.18% 460M
+1.49%-2.55%-56.83%-60.34% 365M
+1.29%-3.67%-21.13%-35.69% 344M
Average +1.71%-2.05%-21.52%-36.80% 2.15B
Weighted average by Cap. -0.78%-6.76%+2.39%-31.04%

Financials

2024 2025
Net sales 501K 667K 586K 546K 941K 63.93M 953K 6.48M 2.53M 31.57M 2.5M 2.45M 109M 954K 1.27M 1.12M 1.04M 1.79M 122M 1.82M 12.35M 4.82M 60.11M 4.77M 4.66M 208M
Net income -7.08M -9.41M -8.28M -7.7M -13.29M -903M -13.46M -91.57M -35.76M -446M -35.34M -34.58M -1.54B -5.23M -6.96M -6.12M -5.7M -9.82M -668M -9.95M -67.7M -26.44M -330M -26.13M -25.57M -1.14B
Net Debt -5.17M -6.88M -6.05M -5.63M -9.71M -660M -9.83M -66.9M -26.13M -326M -25.82M -25.26M -1.13B -1.18M -1.57M -1.38M -1.29M -2.22M -151M -2.25M -15.3M -5.98M -74.48M -5.9M -5.78M -257M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
27/07/26 GBX 1.050 0.00% 957,143
24/07/26 GBX 1.050 0.00% 114,889
23/07/26 GBX 1.050 +2.44% 3,035,275
22/07/26 GBX 1.025 -2.38% 9,394,644
21/07/26 GBX 1.050 0.00% 7,423,712

Annual profits - Rate of surprise